You just read:

MT Pharma America Presents 12-Month RADICAVA™ (Edaravone) and Amyotrophic Lateral Sclerosis Data at the European Network for the Cure of ALS (ENCALS) Annual Meeting

News provided by

MT Pharma America, Inc.

May 18, 2017, 13:42 ET